New volume-forming drug for the treatment of stress urinary incontinence based on poly-ε-caprolactone particles
The development of new methods and minimally invasive technologies for treating stress urinary incontinence in women is one of the most urgent problems of modern gynecology. Тhe promising approaches is the use of periurethral administration of bulking agents that create additional volume in the field of transplantation and aimed at achieving an equilibrium pressure between the bladder and urethra. Thus bulking agents are capable for reducing the frequency of intra-and post-operative complications, as well as ensuring the most effective rehabilitation of patients